← Eichor
Condition: Tumor Microenvironment Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tumor Microenvironment

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

[68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas
Phase 2 · 1 location(s) · John O. Prior · NCT06794372Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06874257Multiomics Tumor Evolution Model of NSCLC
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT05352035Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immun
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06694454Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
Phase N/A · 4 location(s) · Azienda USL Reggio Emilia - IRCCS · NCT07214324Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients
Phase N/A · 1 location(s) · Giampaolo Bianchini · NCT06518382The Role of the Imaging FAPI PET/CT in Exploring the Microenvironment of Colorectal Cancer Liver Metastases
NA · 1 location(s) · Jules Bordet Institute · NCT07109440GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)
Phase N/A · 1 location(s) · Centre Leon Berard · NCT05644431InteGRAtive Analysis of TuMor, Microenvironment, ImmunitY and Patient Expectation for Personalized Response Prediction i
Phase N/A · 5 location(s) · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRS · NCT04842916Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy
Phase N/A · 1 location(s) · The Fourth Affiliated Hospital of Zhejiang University School · NCT05636605Microbiome Immunotherapy Neoadjuvant Assessment
Phase N/A · 1 location(s) · University College Cork · NCT06709651The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes
Phase N/A · 1 location(s) · Changzhi People's Hospital Affiliated to Changzhi Medical Co · NCT07069842Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05941234Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach（Radiogenomic
Phase N/A · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06536998Organoid Models of Hepatocellular Carcinoma
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06929845Role of the Immune Environment in Response to Therapy in Breast Cancer
Phase N/A · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT05396612Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treate
Phase N/A · 1 location(s) · Instituto de Investigación Biomédica de Salamanca · NCT07064330Study of the Medullary Microenvironment in Acute Childhood Leukemia
NA · 3 location(s) · University Hospital, Tours · NCT05792007Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT07180992Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients
Phase 3 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07461948Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
Phase 2 · 7 location(s) · Michael Dill · NCT05690048Cardiac Safety Management and Immune Microenvironment Changes After Thoracic Radiotherapy: A Prospective Observational S
Phase N/A · 1 location(s) · Hebei Medical University Fourth Hospital · NCT07669493Decoding the Extracellular Vesicles-driven Communication in the Microenvironment of Hairy Cell Leukemia to Improve Patie
Phase N/A · 3 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06774677Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach（Radiogenomics-
Phase N/A · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06500312Naltrexone and Propranolol Combined With Immunotherapy
Phase 1 · 1 location(s) · Sarah Weiss · NCT05968690Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06001658Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease
NA · 1 location(s) · Université Catholique de Louvain · NCT07384897Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer?
NA · 1 location(s) · University of Surrey · NCT07375420Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Ly
Phase N/A · 20 location(s) · Fondazione Italiana Linfomi - ETS · NCT06588205Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma
NA · 1 location(s) · Institute of Oncology Ljubljana · NCT07404605
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.